We are committed to changing therapy outcomes and improving the lives of patients whose treatment needs are unmet. We focus on leveraging established regulatory pathways, such as the FDA’s 505(b)2 pathway in the US or equivalent regulatory frameworks in other regions where the safety and efficacy of the molecule have already been established.
Our unique approach reduces costs and risks by lessening the clinical burden required for market entry and shortening development timelines.
We are operating our research & development and boast of state-of-the-art R&D facilities that span 10,000 sq ft. with manufacturing facilities that are US FDA and EU approved.
We work with strategic CMO partners to seamlessly produce and supply to global markets. The CMOs are US/EU/UK approved.
We work closely with our partners to innovate and repurpose proven medications to deliver timely and effective solutions that address unmet medical needs of patients and improve their lives.
As we grow our product pipeline across various indications, we continuously expand co-development and in-licensing opportunities with the keen intent to deliver wellness to patients, and innovation to healthcare professionals.
We are highly motivated to build strategic collaborations and establish productive commercial partnerships to bring value-added products to market. We look forward to working with equally committed organisations to build a better life for people globally.
